Terry C. Vance

Terry C. Vance

DirectoratEnanta Pharmaceuticals· In proxies 2023–2025

Terry C. Vance sits on 1 public board.

Experience

  1. Enanta PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -77%
  2. In accordance with Nasdaq’s recently adopted board diversity listing standards, we are also disclosing aggregated statistical information about our Board’s self-identified gender and racial characteristics and LGBTQ+ status as voluntarily confirmed to us by each of our directors. Each of the categories listed in the table below has the meaning used in Nasdaq Rule 5605(f). The statistical informatiPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?